1. Sackler Institute of Pulmonary Pharmacology and Therapeutics, Division of Pharmaceutical Sciences, School of Biomedical and Health Sciences, King's College, London; and
2. Allergy and Respiratory Biology, Global Research and Development, Pfizer Global Research and Development, Sandwich, United Kingdom